"We selected GammaPod because of its practice-changing potential," said Marco Trovò, MD, head of the Radiotherapy Department at ASUIUD. "In Italy and throughout Europe, our field is moving to treat early stage breast cancer patients with shorter courses of radiation. The GammaPod is completely noninvasive and could potentially allow our patients to receive a full course of treatment in only one to five fractions."
Xcision is represented in Europe by Tema Sinergie S.p.A. in Italy and OncoMed Solutions LLC in Switzerland, Germany and Austria. The company's innovative technology will be on display at the ESTRO 38 meeting in Milan, Italy from April 26 – 30 at booth 2975.
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About Xcision Medical Systems
Xcision Medical Systems, LLC is a medical technology company developing advanced stereotactic radiotherapy solutions with the potential to dramatically raise the quality of treatments and improve the lives of patients and their loved ones. The company's solutions are designed to extend the benefits of radiation oncology to more patients and enable noninvasive treatments that allow patients to return to living fuller lives more quickly and less painfully after receiving a cancer diagnosis.
SOURCE Xcision Medical Systems, LLC
Back to HCB News
